Protective effect of pioglitazone on sepsis-induced intestinal injury in a rodent model

Journal of Surgical Research

Volumn 195, Issue 2, 2015, Pages 550-558

  Gao, Min ^a   Jiang, Yu ^b   Xiao, Xuefei ^a   Peng, Yue ^a   Xiao, Xianzhong ^a,b   Yang, Mingshi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Cecal ligation and puncture; Intestinal injury; Pioglitazone; Sepsis

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; POLYGLACTIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CAVA VEIN; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTERITIS; EXPERIMENTAL PERITONITIS; HISTOPATHOLOGY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT MODEL; SEPSIS; SMALL INTESTINE; STRESS; SURVIVAL RATE; SURVIVAL TIME; VENOUS BLOOD; AGONISTS; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; INTESTINE; METABOLISM; MORTALITY; OXIDATIVE STRESS; PERMEABILITY; SPRAGUE DAWLEY RAT;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; INTESTINES; MALE; OXIDATIVE STRESS; PERMEABILITY; PEROXIDASE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928629612     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.02.007     Document Type: Article

References (47)

1. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138
2. R.P. Wenzel, and M.B. Edmond Septic shock - evaluating another failed treatment N Engl J Med 366 2012 2122
3. J.A. Clark, and C.M. Coopersmith Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness Shock 28 2007 384
4. H.T. Hassoun, B.C. Kone, and D.W. Mercer Post-injury multiple organ failure: the role of the gut Shock 15 2001 1
5. M.P. Fink, and R.L. Delude Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level Crit Care Clin 21 2005 177
6. M. Gatt, B.S. Reddy, and J. MacFie Review article: bacterial translocation in the critically ill - evidence and methods of prevention Aliment Pharmacol Ther 25 2007 741
7. J.C. Alverdy, and E.B. Chang The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away J Leukoc Biol 83 2008 461
8. E.A. Deitch Gut-origin sepsis: evolution of a concept Surgeon 10 2012 350
9. E.A. Deitch Role of the gut lymphatic system in multiple organ failure Curr Opin Crit Care 7 2001 92
10. K. Schoonjans, G. Martin, B. Staels, and J. Auwerx Peroxisome proliferator-activated receptors, orphans with ligands and functions Curr Opin Lipidol 8 1997 159
11. R.B. Clark The role of PPARs in inflammation and immunity J Leukoc Biol 71 2002 388
12. L. Dubuquoy, C. Rousseaux, and X. Thuru PPARgamma as a new therapeutic target in inflammatory bowel diseases Gut 55 2006 1341
13. B. Kiec-Wilk, A. Dembinska-Kiec, A. Olszanecka, M. Bodzioch, and K. Kawecka-Jaszcz The selected pathophysiological aspects of PPARs activation J Physiol Pharmacol 56 2005 149
14. A. Ptak-Belowska, M.W. Pawlik, G. Krzysiek-Maczka, T. Brzozowski, and W.W. Pawlik Transcriptional upregulation of gastrin in response to peroxisome proliferator-activated receptor gamma agonist triggers cell survival pathways J Physiol Pharmacol 58 2007 793
15. P.C. Konturek, A. Dembinski, and Z. Warzecha Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis World J Gastroenterol 11 2005 6322
16. P.C. Konturek, T. Brzozowski, and M. Engel Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves J Physiol Pharmacol 60 2009 41
17. C. Linard, O. Gremy, and M. Benderitter Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist J Pharmacol Exp Ther 324 2008 911
18. M. Adachi, R. Kurotani, and K. Morimura Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease Gut 55 2006 1104
19. Y.M. Shah, K. Morimura, and F.J. Gonzalez Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis Am J Physiol Gastrointest Liver Physiol 292 2007 G657
20. A. Nakajima, K. Wada, and H. Miki Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury Gastroenterology 120 2001 460
21. M. Arita, M. Yoshida, and S. Hong Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis Proc Natl Acad Sci U S A 102 2005 7671
22. H.T. Ten, A. Corbaz, and H. Amitai Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice Gastroenterology 121 2001 1372
23. M. Nakai, K. Sudo, and Y. Yamada The role of the tumor necrosis factor receptor in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice Dig Dis Sci 50 2005 1669
24. E. Hollenbach, M. Vieth, A. Roessner, M. Neumann, P. Malfertheiner, and M. Naumann Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease J Biol Chem 280 2005 14981
25. Y. Tsujimura, T. Matsutani, and A. Matsuda Effects of pioglitazone on survival and omental adipocyte function in mice with sepsis induced by cecal ligation and puncture J Surg Res 171 2011 e215
26. M. Kutsukake, T. Matsutani, and K. Tamura Pioglitazone attenuates lung injury by modulating adipose inflammation J Surg Res 189 2014 295
27. J.A. Clark, H. Gan, A.J. Samocha, A.C. Fox, T.G. Buchman, and C.M. Coopersmith Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis Am J Physiol Gastrointest Liver Physiol 297 2009 G471
28. M. Kajiya, M.J. Silva, K. Sato, K. Ouhara, and T. Kawai Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate Biochem Biophys Res Commun 386 2009 11
29. M. Kawaguchi-Suzuki, and R.F. Frye Current clinical evidence on pioglitazone pharmacogenomics Front Pharmacol 4 2013 147
30. B. Cariou, B. Charbonnel, and B. Staels Thiazolidinediones and PPARγ agonists: time for a reassessment Trends Endocrinol Metab 23 2012 205
31. N. Baregamian, J.M. Mourot, A.R. Ballard, B.M. Evers, and D.H. Chung PPAR-gamma agonist protects against intestinal injury during necrotizing enterocolitis Biochem Biophys Res Commun 379 2009 423
32. O. De Backer, E. Elinck, E. Priem, L. Leybaert, and R.A. Lefebvre Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes J Pharmacol Exp Ther 331 2009 496
33. G.M. Koksal, C. Sayilgan, S. Aydin, H. Oz, and H. Uzun Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis J Surg Res 122 2004 180
34. S. Sakaguchi, and S. Furusawa Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia FEMS Immunol Med Microbiol 47 2006 167
35. C. Zou, H. Hu, X. Xi, Z. Shi, G. Wang, and X. Huang Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity J Surg Res 184 2013 1092
36. A.A. El-Sheikh, and R.A. Rifaai Peroxisome proliferator activator receptor (PPAR)-gamma ligand, but not PPAR-alpha, ameliorates cyclophosphamide-induced oxidative stress and inflammation in rat liver PPAR Res 2014 2014 626319
37. R.F. Al, and E.E. El PPAR-gamma activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress Exp Gerontol 51 2014 1
38. F.K. Swirski, M. Wildgruber, and T. Ueno Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice J Clin Invest 120 2010 2627
39. J. Grommes, S. Vijayan, and M. Drechsler Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation PLoS One 7 2012 e38917
40. M. Asaduzzaman, M. Rahman, B. Jeppsson, and H. Thorlacius P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis Br J Pharmacol 156 2009 307
41. S. Zhang, S. Zhang, M. Rahman, H. Herwald, and H. Thorlacius Streptococcal M1 protein-induced lung injury is independent of platelets in mice Shock 35 2011 86
42. S.M. Smith, R.H. Eng, and F. Buccini Use of D-lactic acid measurements in the diagnosis of bacterial infections J Infect Dis 154 1986 658
43. J.S. Thompson, W.P. Vaughan, C.F. Forst, D.L. Jacobs, J.S. Weekly, and L.F. Rikkers The effect of the route of nutrient delivery on gut structure and diamine oxidase levels JPEN J Parenter Enteral Nutr 11 1987 28
44. S. Shebrain, and A. Ramjit Radicicol, a Hsp90 inhibitor, inhibits intestinal inflammation and leakage in abdominal sepsis J Surg Res 185 2013 e53
45. S.S. Short, J. Wang, and S.L. Castle Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis Lab Invest 93 2013 1265
46. K.A. Wichterman, A.E. Baue, and I.H. Chaudry Sepsis and septic shock - a review of laboratory models and a proposal J Surg Res 29 1980 189
47. W.J. Hubbard, M. Choudhry, and M.G. Schwacha Cecal ligation and puncture Shock 24 Suppl 1 2005 52